Development of new generation of vaccines based on recombinant vaccinia virus III.
Project goals
Development of sale and efficient experimental recombinant vaccine against varicella-zoster virus (VZV) on the basis of vaccinia virus (strains and MVA). Investigation of VZV DNA immunogenicity.
Keywords
Public support
Provider
Ministry of Health
Programme
—
Call for proposals
—
Main participants
Ústav hematologie a krevní transfúze
Contest type
—
Contract ID
—
Alternative language
Project name in Czech
Vývoj nové generace vakcín založených na rekombinantním viru vakcinie III
Annotation in Czech
Vřvoj bezpeŔnÚ a ˙ŔinnÚ experimentßlnÝ rekombinantnÝ vakciny proti viru varicella zoster(VZV) na bazi viru vakcinie(kmeny Praha a MVA).Prový°enÝ imunogennosti DNA VZV na laborator.zvÝ°atech.
Scientific branches
Solution timeline
Realization period - beginning
Jan 1, 1997
Realization period - end
Jan 1, 1999
Project status
K - Ending multi-year project
Latest support payment
—
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP/1999/MZ0/MZ09IZ/V/2:2
Data delivery date
—
Finance
Total approved costs
5,376 thou. CZK
Public financial support
3,658 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
0 thou. CZK
Recognised costs
5 376 CZK thou.
Public support
3 658 CZK thou.
0%
Provider
Ministry of Health
CEP
FN - Epidemiology, infection diseases and clinical immunology
Solution period
01. 01. 1997 - 01. 01. 1999